Novel substituted benzimidazole dosage forms and method of using same

摘要

The invention concerns a solid pharmaceutical dosage form capable of direct oral administration to a subject comprising at least one proton pump inhibitor in an amount of about 2 mg to about 300 mg; at least one buffering agent; and optionally one or more pharmaceutically acceptable excipients; and the use of such a dosage form in the manufacture of a medicament for treating a gastrointestinal disorder in a subject in need thereof. <IMAGE>